Effects of vitamin E on pathological changes induced by diabetes in rat lungs

Respiratory Physiology and Neurobiology

Volumn 185, Issue 3, 2013, Pages 593-599

  Alireza, Shirpoor ^a   Leila, Norouzi ^a   Siamak, Salami ^b   Mohammad Hasan, Khadem Ansari ^a   Behrouz, Ilkhanizadeh ^a  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes; Lung; Rat; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CATHEPSIN G; GLYCOGEN; SERINE PROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; DIABETES MELLITUS; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS WALL; LUNG PARENCHYMA; MALE; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TISSUE LEVEL;

ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, EXPERIMENTAL; ELECTROPHORESIS, CAPILLARY; LUNG; MALE; RATS; RATS, WISTAR; VITAMIN E; VITAMINS;

EID: 84872370639     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2012.11.017     Document Type: Article

References (52)

1. Alba-Loureiro T.C., Martins E.F., Landgraf R.G., Jancar S., Curi R., Sannomiya P. Role of insulin on PGE2 generation during LPS-induced lung inflammation in rats. Life Sciences 2006, 78:578-585.
2. Ashcroft T., Simpson J.M., Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. Journal of Clinical Pathology 1988, 41:467-470.
3. Azzi A., Breyer I., Feher M., Pastori M., Ricciarelli R., Spycher S., Staffieri M., Stocker A., Zimmer S., Zingg J.M. Specific cellular responses to alpha-tocopherol. Journal of Nutrition 2000, 130:1649-1652.
4. Azzi A., Ricciarelli R., Zingg J.M. Non-antioxidant molecular functions of alpha-tocopherol (vitamin E). FEBS Letters 2002, 519:8-10.
5. Badger T.M., Ronis M.J., Lumpkin C.K., Valentine C.R., Shahare M., Irby D., Huang J., Mercado C., Thomas P., Ingelman-Sundberg M., et al. Effects of chronic ethanol on growth hormone secretion and hepatic cytochrome P450 isozymes of the rat. Journal of Pharmacology and Experimental Therapeutics 1993, 264:438-447.
6. Bossuyt X., Lissoir B., Marien G., Maisin D., Vunckx J., Blanckaert N., Wallemacq P. Automated serum protein electrophoresis by Capillarys. Clinical Chemistry and Laboratory Medicine 2003, 41:704-710.
7. Boxer L.A., Smolen J.E. Neutrophil granule constituents and their release in health and disease. Hematology/Oncology Clinics of North America 1988, 2:101-134.
8. Dalquen P. The lung in diabetes mellitus. Respiration 1999, 66:12-13.
9. Davis W.L., Crawford L.A., Cooper O.J., Farmer G.R., Thomas D.L., Freeman B.L. Ethanol induces the generation of reactive free radicals by neural crest cells in vitro. Journal of Craniofacial Genetics and Developmental Biology 1990, 10:277-293.
10. De Andrea M., Ravotto M., Noris E., Ying G.G., Gioia D., Azzimonti B., Gariglio M., Landolfo S. The interferon-inducible gene, Ifi204, acquires malignant transformation capability upon mutation at the Rb-binding sites. FEBS Letters 2002, 515:51-57.
11. Devaraj S., Leonard S., Traber M.G., Jialal I. Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radical Biology and Medicine 2008, 44:1203-1208.
12. Forgiarini L.A., Kretzmann N.A., Porawski M., Dias A.S., Marroni N.A. Experimental diabetes mellitus: oxidative stress and changes in lung structure. Jornal Brasileiro de Pneumologia 2009, 35:788-791.
13. Foster J.A., Bruenger E., Rubin L., Imberman M., Kagan H., Mecham R., Franzblau C. Circular dichroism studies of an elastin crosslinked peptide. Biopolymers 1976, 15:833-841.
14. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs and Aging 2001, 18:685-716.
15. Hand W.L., Hand D.L., Vasquez Y. Increased polymorphonuclear leukocyte respiratory burst function in type 2 diabetes. Diabetes Research and Clinical Practice 2007, 76:44-50.
16. Haskins K., Bradley B., Powers K., Fadok V., Flores S., Ling X., Pugazhenthi S., Reusch J., Kench J. Oxidative stress in type 1 diabetes. Annals of the New York Academy of Sciences 2003, 1005:43-54.
17. Heinecke J.W., Rosen H., Suzuki L.A., Chait A. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. Journal of Biological Chemistry 1987, 262:10098-10103.
18. Hogg N. The effect of cyst(e)ine on the auto-oxidation of homocysteine. Free Radical Biology and Medicine 1999, 27:28-33.
19. Hurdag C., Uyaner I., Gurel E., Utkusavas A., Atukeren P., Demirci C. The effect of alpha-lipoic acid on NOS dispersion in the lung of streptozotocin-induced diabetic rats. Journal of Diabetes and its Complications 2008, 22:56-61.
20. Irfan M., Jabbar A., Haque A.S., Awan S., Hussain S.F. Pulmonary functions in patients with diabetes mellitus. Lung India 2011, 28:89-92.
21. Janoff A. Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis. American Review of Respiratory Disease 1985, 132:417-433.
22. Janoff A., Feinstein G., Malemud C.J., Elias J.M. Degradation of cartilage proteoglycan by human leukocyte granule neutral proteases-a model of joint injury. I. Penetration of enzyme into rabbit articular cartilage and release of 35SO4-labeled material from the tissue. Journal of Clinical Investigation 1976, 57:615-624.
23. Janusz M.J., Hare M. Inhibition of human neutrophil elastase and cathepsin G by a biphenyl disulfonic acid copolymer. International Journal of Immunopharmacology 1994, 16:623-632.
24. Jiang H., Wang X.F., Fang L., Tang C., Zhu Y., Wang X. Upregulation of aldose reductase by homocysteine in type II alveolar epithelial cells. Biochemical and Biophysical Research Communications 2005, 337:1084-1091.
25. Kaparianos A., Argyropoulou E., Sampsonas F., Karkoulias K., Tsiamita M., Spiropoulos K. Pulmonary complications in diabetes mellitus. Chronic Respiratory Disease 2008, 5:101-108.
26. Koya D., King G.L. Protein kinase C activation and the development of diabetic complications. Diabetes 1998, 47:859-866.
27. Kuziemski K., Specjalski K., Jassem E. Diabetic pulmonary microangiopathy - fact or fiction?. Endokrynologia Polska 2011, 62:171-176.
28. Lamharzi N., Renard C.B., Kramer F., Pennathur S., Heinecke J.W., Chait A., Bornfeldt K.E. Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL. Diabetes 2004, 53:3217-3225.
29. Lee W.L., Downey G.P. Neutrophil activation and acute lung injury. Current Opinion in Critical Care 2001, 7:1-7.
30. Ljubic S., Metelko Z., Car N., Roglic G., Drazic Z. Reduction of diffusion capacity for carbon monoxide in diabetic patients. Chest 1998, 114:1033-1035.
31. Lungarella G., Cavarra E., Lucattelli M., Martorana P.A. The dual role of neutrophil elastase in lung destruction and repair. International Journal of Biochemistry and Cell Biology 2008, 40:1287-1296.
32. Matsumoto I., Burke L., Inoue Y., Wilce P.A. Two models of ethanol withdrawal kindling. Nihon Arukoru Yakubutsu Igakkai Zasshi 2001, 36:53-64.
33. Ohnishi T., Bandow K., Kakimoto K., Machigashira M., Matsuyama T., Matsuguchi T. Oxidative stress causes alveolar bone loss in metabolic syndrome model mice with type 2 diabetes. Journal of Periodontal Research 2009, 44:43-51.
34. Pages G., Rouayrenc J.F., Le Cam G., Mariller M., Le Cam A. Molecular characterization of three rat liver serine-protease inhibitors affected by inflammation and hypophysectomy. Protein and mRNA analysis and cDNA cloning. European Journal of Biochemistry 1990, 190:385-391.
35. Patterson C.E., Barnard J.W., Lafuze J.E., Hull M.T., Baldwin S.J., Rhoades R.A. The role of activation of neutrophils and microvascular pressure in acute pulmonary edema. American Review of Respiratory Disease 1989, 140:1052-1062.
36. Pitocco D., Fuso L., Conte E.G., Zaccardi F., Condoluci C., Scavone G., Incalzi R.A., Ghirlanda G. The diabetic lung - a new target organ?. The Review of Diabetic Studies 2012, 9:23-35.
37. Quinn D.J., Weldon S., Taggart C.C. Antiproteases as therapeutics to target inflammation in cystic fibrosis. The Open Respiratory Medicine Journal 2010, 4:20-31.
38. Reilly C.F., Travis J. The degradation of human lung elastin by neutrophil proteinases. Biochimica et Biophysica Acta 1980, 621:147-157.
39. Reinhart P.G., Bassett D.J., Bhalla D.K. The influence of polymorphonuclear leukocytes on altered pulmonary epithelial permeability during ozone exposure. Toxicology 1998, 127:17-28.
40. Shiels B.R., Northemann W., Gehring M.R., Fey G.H. Modified nuclear processing of alpha 1-acid glycoprotein RNA during inflammation. Journal of Biological Chemistry 1987, 262:12826-12831.
41. Shirpoor A., Ansari M.H., Salami S., Pakdel F.G., Rasmi Y. Effect of vitamin E on oxidative stress status in small intestine of diabetic rat. World Journal of Gastroenterology 2007, 13:4340-4344.
42. Shirpoor A., Salami S., Khadem-Ansari M.H., Ilkhanizadeh B., Pakdel F.G., Khademvatani K. Cardioprotective effect of vitamin E: rescues of diabetes-induced cardiac malfunction, oxidative stress, and apoptosis in rat. Journal of Diabetes and its Complications 2009, 23:310-316.
43. Sibille Y., Reynolds H.Y. Macrophages and polymorphonuclear neutrophils in lung defense and injury. American Review of Respiratory Disease 1990, 141:471-501.
44. Streck E.L., Vieira P.S., Wannmacher C.M., Dutra-Filho C.S., Wajner M., Wyse A.T. In vitro effect of homocysteine on some parameters of oxidative stress in rat hippocampus. Metabolic Brain Disease 2003, 18:147-154.
45. Tetley T.D. New perspectives on basic mechanisms in lung disease. 6. Proteinase imbalance: its role in lung disease. Thorax 1993, 48:560-565.
46. Upchurch G.R., Welch G.N., Fabian A.J., Freedman J.E., Johnson J.L., Keaney J.F., Loscalzo J. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. Journal of Biological Chemistry 1997, 272:17012-17017.
47. van den Borst B., Gosker H.R., Zeegers M.P., Schols A.M. Pulmonary function in diabetes: a metaanalysis. Chest 2010, 138:393-406.
48. van Gent R., Brackel H.J., de Vroede M., van der Ent C.K. Lung function abnormalities in children with type I diabetes. Respiratory Medicine 2002, 96:976-978.
49. Vessey D.A., Lee K.H. Inactivation of enzymes of the glutathione antioxidant system by treatment of cultured human keratinocytes with peroxides. Journal of Investigative Dermatology 1993, 100:829-833.
50. Voynow J.A., Fischer B.M., Zheng S. Proteases and cystic fibrosis. International Journal of Biochemistry and Cell Biology 2008, 40:1238-1245.
51. Way K.J., Katai N., King G.L. Protein kinase C and the development of diabetic vascular complications. Diabetic Medicine 2001, 18:945-959.
52. Wyse A.T., Zugno A.I., Streck E.L., Matte C., Calcagnotto T., Wannmacher C.M., Wajner M. Inhibition of Na(+),K(+)-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment. Neurochemical Research 2002, 27:1685-1689.